Many medical devices are reusable and need maintenance and repair. Servicing of devices is critical to their safe and effective use. The U.S. Food and Drug Administration (FDA) has issued two documents as part of its ongoing efforts to help distinguish between remanufacturing and servicing. To clarify the activities that are likely “remanufacturing” of a device, the FDA issued the draft guidance: Remanufacturing of Medical Devices.
Read the Guidance »
Facts about the draft guidance
Discussion paper on cybersecurity and servicing
The FDA is also committed to strong cybersecurity practices related to the servicing of medical devices and is releasing a discussion paper, Strengthening Cybersecurity Practices Associated with Servicing of Medical Devices: Challenges and Opportunities, to outline cybersecurity issues that are unique to the servicing of medical devices.
Read the Paper »
Upcoming webinar on this guidance
On July 27, the FDA will host a webinar for stakeholders interested in learning more about the guidance and discussion paper.
This draft guidance will be open for public comments for 60 days at https://www.regulations.gov under Docket Number FDA-2018-N-3741.
The discussion paper will be open for public comments for 60 days at https://www.regulations.gov under Docket Number FDA-2021-N-0561.
If you have questions about this draft guidance or the discussion paper, contact the Division of Industry and Consumer Education.
*By entering your email address, you agree to receive emails regarding TechNation Magazine, Webinars, and Exclusive Promos.
© 2021, TechNation Magazine. Site designed by MD Publishing, Inc.